I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Pregabalin (Lyrica): Effect, Dosage, Risks and Stopping
Pregabalin, usually known as Lyrica, is a versatile medication for nerve pain, generalized anxiety disorder, and epilepsy — and at the same time a well-known substance of misuse. About 4% of adults suffer from chronic nerve pain (a broadly applicable figure), many of them inadequately treated. Unlike gabapentin, pregabalin has a higher misuse potential — in combination with opioids there is a life-threatening risk of respiratory depression.
Pregabalin has a misuse potential. Never stop abruptly. The combination with opioids can lead to life-threatening respiratory depression. Dose adjustment with renal impairment. Last updated: May 2026.
1. At a glance: technical data sheet
Pregabalin is a gabapentinoid with three main indications - nerve pain, generalised anxiety disorder, and epilepsy. Below are the most important key facts for a quick orientation; the individual points are explained in detail in the following chapters.
Property
Details
Active substance
Pregabalin - a gabapentinoid (related to gabapentin)
Trade names
Lyrica, pregabalin generics
ATC code
N03AX16 - antiepileptics (gabapentinoids)
Mechanism of action
Binding to the α2δ subunit of voltage-gated calcium channels - dampens the over-excitability of nerve cells
Tapering in from 150 mg/day, often 300–600 mg/day, split over 2 single doses; max. 600 mg/day
Onset of effect
With anxiety disorder often as early as the first week; with nerve pain 1–2 weeks after the target dose
Pharmacokinetics
Linear absorption (unlike gabapentin), no liver metabolism, renal excretion
Intake frequency
Twice daily (unlike gabapentin 3×)
Misuse potential
Relevant - higher than gabapentin, euphoria-inducing in higher doses
Most important risk
Respiratory depression in combination with opioids, benzodiazepines, or alcohol
Prescription status
Yes
Table scrolls to the right
2. What is pregabalin?
Pregabalin is a versatile medication that is used with nerve pain, generalised anxiety disorder, and epilepsy. It is known above all under the trade name Lyrica; there are numerous generics. Pregabalin belongs, together with gabapentin, to the group of the gabapentinoids - both work via the same mechanism, but differ in a few important points.
A particularity of pregabalin is its threefold indication - above all the approval with generalised anxiety disorder distinguishes it from gabapentin and makes it an important agent also in psychiatry. It works pain-relievingly, anxiety-relievingly, and seizure-suppressingly at the same time.
Pregabalin is mostly well tolerated and often works more quickly than gabapentin. At the same time it has a higher misuse potential and has become known as a substance of misuse - a topic that we treat factually and with a safety orientation. Also important: the risk in combination with opioids (respiratory depression), the stopping, and the slow dose build-up.
3. How does pregabalin work pharmacologically?
Pregabalin binds - like gabapentin - to the α2δ subunit of voltage-gated calcium channels at the nerve endings. Thereby the calcium influx into the nerve cell is reduced and the release of excitatory messenger substances is dampened. The result is a reduced over-excitability of the nerve cells.
This dampening works therapeutically at several points: it reduces the misdirected pain transmission with nerve pain, dampens the neuronal over-excitation with seizures, and works anxiety-relievingly via the influencing of certain brain regions. The anxiety-relieving effect is a unique selling point over gabapentin.
Pharmacokinetics in brief
Unlike gabapentin, pregabalin has an even, well-predictable absorption in the gut (linear pharmacokinetics) - that allows the twice-daily intake and a faster dose build-up. Pregabalin is not metabolised in the liver, but excreted unchanged via the kidneys - therefore few liver interactions, but an important dose adjustment with renal impairment (a separate chapter).
Focal seizures, when other antiepileptics alone are not sufficient
Add-on therapy
Table scrolls to the right
5. Pregabalin with generalised anxiety disorder
An important area of use that distinguishes pregabalin from gabapentin. With generalised anxiety disorder (GAD) - characterised by persistent, excessive worries, inner tension, restlessness, and physical symptoms - pregabalin is an approved treatment option.
An anxiety-relieving effect without the classic benzodiazepine profile - pregabalin is not addictive in the same way as benzodiazepines (but has its own misuse potential)
The onset of effect often faster than with antidepressants (SSRIs/SNRIs), which are likewise used with GAD
Classification: pregabalin is one of several options with GAD - alongside SSRIs/SNRIs (agents of first choice) and psychotherapy
Combination with psychotherapy for the best and most lasting results
Important: an anxiety disorder should be treated comprehensively - psychotherapy (above all cognitive behavioural therapy) is a central building block. Pregabalin can be the medication component, but does not replace the psychotherapeutic and psychosocial treatment. The choice is made by the doctor weighing effect, tolerability, and misuse risk.
6. Dosage and intake
Pregabalin is dosed by tapering in, but because of the even absorption can be built up faster than gabapentin and taken only twice daily:
A tapering-in start: often 150 mg/day (split over 2 doses), increase according to effect and tolerability
Split over 2 single doses daily (morning and evening)
Usual effective dose: 300–600 mg/day, depending on the indication and response
Maximum dose: 600 mg/day
Renal impairment: a clear dose reduction necessary (a separate chapter)
The most important intake notes
Twice daily at about the same times (morning and evening)
With or without food possible
Build up the dose slowly according to the medical scheme - against dizziness and tiredness
With a forgotten dose: make up as soon as possible; do not double
Never stop abruptly - taper off (a separate chapter)
Do not raise the dose on your own - particularly important because of the misuse potential
7. When does pregabalin work - and how fast?
An advantage of pregabalin is the often faster onset of effect than with gabapentin or with antidepressants. Since it is absorbed evenly and can be built up faster, the effect is often assessable earlier:
With nerve pain: first relief often within the first days to 1–2 weeks after reaching a sufficient dose
With anxiety disorder: the anxiety-relieving effect often noticeable as early as the first week - faster than SSRIs/SNRIs
Side effects (tiredness, dizziness) often occur first and frequently improve in the course
Full assessment after reaching the target dose and some weeks
The relatively fast onset of effect is a practical advantage - above all with anxiety disorder, where the early response eases the adherence to therapy. With an absent effect despite an adequate dose, the therapy is adjusted or switched.
8. Common side effects
Pregabalin has a similar side-effect profile to gabapentin - the most common affect the nervous system and occur above all at the start:
Tiredness, sleepiness - very common, above all in the dose-build-up phase
Euphoria/elevated mood - relevant for the misuse potential
Constipation
Most side effects are dose-dependent and improve after the adjustment. The slow dose build-up reduces tiredness and dizziness. The occasionally occurring feeling of euphoria or relaxation is one reason for the misuse potential (a separate chapter). As with antiepileptics in general, watch for depressive mood or suicidal thoughts.
9. Dependence and misuse
A central and serious topic with pregabalin - more pronounced than with gabapentin. Pregabalin has a relevant misuse and dependence potential and has become known as a substance of misuse, above all in higher doses and in certain scenes.
A euphoria-inducing/relaxing effect in higher doses - the reason for the misuse potential
A higher misuse risk than gabapentin - above all with a pre-existing addiction and in combination with other substances (opioids, benzodiazepines, alcohol)
Physical habituation possible even with use as intended (hence the tapering off)
In some countries pregabalin is therefore more strictly regulated (partly as a controlled substance)
Warning signs of problematic use: dose increase beyond the prescription, intake to influence mood, craving, procurement from several sources, loss of control
Pregabalin misuse is dangerous
Above all in high doses and in combination with opioids, benzodiazepines, or alcohol, there is a risk of respiratory depression (see next chapter). Take pregabalin only on medical prescription and exactly according to instruction, never to get intoxicated, and never pass it on to others. With a pre-existing addiction, particular caution is required. A dependence is treatable - early action is decisive.
10. Caution: pregabalin and opioids
A particularly important safety topic - as with gabapentin. The combination of pregabalin with opioids (strong painkillers such as tilidine, tramadol, morphine) raises the risk of respiratory depression - a dangerous dampening of the breathing up to respiratory arrest.
Life-threatening respiratory depression possible
The simultaneous use of pregabalin and opioids (or other strongly dampening agents such as benzodiazepines) can lead to life-threatening respiratory depression. Authorities such as the BfArM (Germany) and the FDA have expressly pointed this out. This combination may take place only under careful medical weighing and monitoring - never combine on your own. Warning signs, call the emergency services immediately (112; or 999/112 in the UK): pronounced sleepiness, slowed/shallow breathing, confusion.
Particularly at risk are older people, patients with respiratory diseases, impaired kidney function, and those who take several dampening substances. This combination is also a common factor in deaths in connection with pregabalin misuse - a further reason for responsible handling.
11. Stopping pregabalin
Pregabalin may not be stopped abruptly - neither with the pain, anxiety, nor epilepsy therapy. A sudden stopping can trigger a discontinuation syndrome and provoke seizures in epilepsy patients.
Possible discontinuation symptoms:sleep disorders, restlessness, anxiety, nausea, headaches, diarrhoea, sweating, irritability, flu-like symptoms - and with epilepsy the risk of seizures. With longer use and higher doses, the discontinuation symptoms can be more pronounced.
Never stop abruptly - always taper off medically accompanied
A step-by-step dose reduction over at least one week, often longer (depending on dose and duration)
With epilepsy particularly careful - abrupt stopping can trigger seizures
With stronger discontinuation symptoms slow the pace
End in a planned way - not on your own, but with medical accompaniment
12. Interactions with other medications
Pregabalin is not metabolised via the liver, which is why it has few classic metabolic interactions. Important, however, are the additive dampening effects:
With pregabalin, caution is required on the topic of alcohol - because of the enhanced dampening and the misuse aspect:
Enhanced tiredness, dizziness, and light-headedness - pregabalin and alcohol both dampen the central nervous system
A raised fall risk through enhanced unsteadiness of gait
Impaired reaction and judgement - dangerous in road traffic
In combination with further dampening agents (opioids, benzodiazepines) an additionally raised respiratory depression risk
Misuse aspect: the combination of pregabalin and alcohol is partly sought to enhance the effect - particularly dangerous
Practical recommendation: during the pregabalin therapy, avoid alcohol or restrict it strongly - especially in the dose-build-up phase and with the simultaneous intake of other dampening medications. When in doubt, discuss with the doctor.
14. Pregabalin vs. gabapentin
The two gabapentinoids in a direct comparison - they work via the same mechanism, but differ in practice:
Aspect
Pregabalin
Gabapentin
Absorption in the gut
Even, linear, predictable
Saturable, non-linear
Intake frequency
2× daily
3× daily
Dose build-up
Faster possible
Slower
Onset of effect
Faster
Somewhat slower
Anxiety-disorder approval
Yes
No
Misuse potential
Higher
Somewhat lower
Respiratory depression with opioids
Yes
Yes
Renal excretion
Yes
Yes
Costs
Higher
Often cheaper
Table scrolls to the right
Clinical rule of thumb: pregabalin is, through the twice-daily administration, faster dose build-up, and the anxiety approval, more practical in some situations, but has a higher misuse potential. Gabapentin is often cheaper and somewhat less at risk of misuse. The choice is made by the doctor individually - with a history of addiction, particular caution is required.
15. Pregabalin in older people and with renal impairment
Since pregabalin is excreted unchanged via the kidneys, the kidney function is decisive for the dosing:
With impaired kidney function the dose must be reduced clearly - otherwise pregabalin accumulates and the side effects (tiredness, dizziness, in severe cases disturbances of consciousness) increase
Older people often have impaired kidney function - dose adjustment and caution
A raised fall risk through dizziness and unsteadiness of gait
A raised risk of respiratory depression in combination with opioids - particularly relevant in older people
Polypharmacy - heed interactions with other dampening agents
Start low, increase slowly, observe closely
With dialysis patients, special dosing rules apply. The exact adjustment to the kidney function belongs in medical hands.
16. When to the doctor? (warning signs)
Pronounced sleepiness, slowed/shallow breathing - suspected respiratory depression (above all with opioids) - an emergency
Depressive mood or suicidal thoughts
Signs of problematic use (dose increase, craving, loss of control)
Pronounced dizziness with a risk of falling
Strong water retention, clear weight gain
Allergic reactions, skin rash (rarely severe skin reactions, angioedema)
With epilepsy: increased seizures
An absent effect despite an adequate dose
A wish to stop the medication - for an accompanied tapering off
The emergency services immediately (112; or 999/112 in the UK)
With pronounced sleepiness with slowed/shallow breathing (suspected respiratory depression, above all with opioids/sedatives), a severe allergic reaction or swelling of the face/lips/tongue (angioedema), acute suicidality, or a seizure (with abrupt stopping).
17. What you can do yourself: 10 golden rules
Build up the dose slowlyAccording to the medical scheme - against dizziness and tiredness.
Twice daily at the same timesConstant intake for an even effect.
Caution with driving at the startUntil the tolerability is clear - tiredness and dizziness are common.
No combination with opioids, sedatives, alcoholWithout medical consultation - a respiratory depression risk.
Do not raise the dose on your ownParticularly important because of the misuse potential.
Never pass it on to othersPregabalin is prescription-only and can endanger others.
Watch the moodTake depressive mood or suicidal thoughts seriously.
Never stop abruptlyTaper off medically accompanied - a seizure risk with epilepsy.
With kidney disease, an adjusted doseA risk of accumulation with reduced kidney function.
With anxiety disorder: psychotherapy as a central building blockThe medication alone is rarely ideal - cognitive behavioural therapy as the basis.
18. How brite supports you with pregabalin
Transparency notice
brite is a health app. The following features refer to functionality within the app and do not replace medical care.
Intake reminder: take pregabalin on time twice daily - brite reminds you reliably.
Interaction check: check opioids, benzodiazepines, and other dampening medications for free - recognise the important respiratory depression risk.
Dose-build-up accompaniment: track the step-by-step tapering in in a structured way.
Document the stopping plan: accompany the slow tapering off.
Health history: document pain, anxiety symptoms, effect, and side effects - valuable for the medical therapy steering.
Digital medication plan: all medications clearly laid out for the GP, neurologist, psychiatrist, pain therapist, and pharmacy.
Note
Anonymised observations from brite app user data; do not replace clinical studies.
Observation
Frequency
Typical comment
Fast relief with anxiety disorder in the first week
Very common
"After years of searching, Lyrica was the first thing that noticeably relieved my generalised anxiety within a week."
Strong tiredness in the dose-build-up phase
Very common
"In the first 2 weeks I was barely functional during the day - my doctor then built up the dose more slowly."
Weight gain as the main problem
Common
"Gained 8 kg in 6 months - although the pain was gone, I wanted out of the medication."
Calf cramps and oedema
Common
"Swollen ankles from day 5 - my GP reduced the dose, now it is fine."
Problematic use after a history of addiction
Common
"I did not tell my doctor that I used to be an alcoholic - the dose increase became a problem, now in withdrawal."
Respiratory depression with tilidine
Rare, but dramatic
"My husband had tilidine for back pain and Lyrica - one night he was barely breathing, the emergency doctor saved him."
Table scrolls to the right
Pregabalin experiences: what people really ask
Pregabalin experiences with nerve pain - does it really work?Yes, clearly in many patients - above all with diabetic polyneuropathy, postherpetic neuralgia (after shingles), and other neuropathic pain. Classic painkillers (paracetamol, ibuprofen) often work poorly here, because they attack at the "wrong place". Pregabalin dampens the misdirected pain transmission in the nervous system. What to expect: first relief after 1–2 weeks after reaching a sufficient dose, an individual response rate of 30–50 % for a significant pain reduction. Important: realistic expectations - a 50% pain reduction already counts as a good success, complete freedom from pain is rare. With a non-response after 4–6 weeks with a sufficient dose, consider alternatives (duloxetine, amitriptyline, local therapies).
Pregabalin with anxiety disorder - faster than antidepressants?Yes, that is one of the advantages. While SSRIs and SNRIs need 2–6 weeks until the anti-anxiety effect sets in, pregabalin is often noticeably effective as early as the first week. That makes it an option for patients who need fast relief - for example with acutely stressful phases of life or before other therapies take hold. But: pregabalin is not a first choice with generalised anxiety disorder - that, according to the S3 guideline, is SSRIs/SNRIs plus psychotherapy. Pregabalin is used above all when these do not work sufficiently or are not tolerated. Important: psychotherapy (above all cognitive behavioural therapy) is the central building block - pregabalin is the medication accompaniment, not the replacement.
Pregabalin or gabapentin - which is better? Both work via the same mechanism, but pregabalin has practical advantages: twice-daily instead of three-times-daily intake, faster dose build-up, faster onset of effect, additional approval with anxiety disorder. Gabapentin, on the other hand, has: a lower misuse potential, often lower costs, longer experience. Rule of thumb: with nerve pain without accompanying diseases, both are possible. With an anxiety-disorder component, pregabalin. With a history of addiction or a misuse risk, rather gabapentin. With renal insufficiency, both with dose adjustment. More details under gabapentin.
Pregabalin misuse - how common is that? Pregabalin has become known as a substance of misuse, above all since about 2015. Studies from Germany and Sweden show a clear rise in misuse, above all in people with addictions (those dependent on opioids, alcoholics) and in certain social scenes. In higher doses (often 600–1500 mg), pregabalin works euphoria-inducingly and relaxingly, similar to benzodiazepines. Risk factors: a history of addiction, simultaneous use of opioids/benzodiazepines, previous polydrug use. Practical consequences: doctors are today more cautious with the prescription; in some countries (e.g. the United Kingdom) pregabalin is regulated as a controlled substance. With a pre-existing addiction, gabapentin or a non-addictive medication is often the better choice.
Stopping pregabalin - how does that work correctly? Pregabalin may never be stopped abruptly - even when there is no classic addiction in the narrower sense. The discontinuation syndrome includes sleep disorders, restlessness, anxiety, nausea, sweating, irritability, flu-like symptoms - with epilepsy additionally a seizure risk. Scheme: a step-by-step reduction over at least one week, often longer - e.g. from 600 mg → 450 mg → 300 mg → 150 mg → 75 mg → stop, 1 week each. With higher doses and longer use slower (a reduction every 2 weeks). Important: accompany medically, slow the pace with discontinuation symptoms. With use in the context of an addiction specialised addiction therapy is necessary - here no self-stopping.
FAQ: common questions about pregabalin
Pregabalin has three main indications: neuropathic (nerve) pain, generalised anxiety disorder, and epilepsy (as add-on therapy). The approval with anxiety disorder distinguishes it from gabapentin. It dampens the over-excitability of nerve cells and thereby works pain-relievingly, anxiety-relievingly, and seizure-suppressingly. The indication and dosing are set by the doctor.
Yes - pregabalin is approved for the treatment of generalised anxiety disorder and works anxiety-relievingly, often faster than antidepressants (SSRIs/SNRIs). It does not have the classic benzodiazepine dependence profile, but its own misuse potential. It is one of several options with anxiety disorders - alongside SSRIs/SNRIs and above all psychotherapy, which remains a central building block of the treatment.
Pregabalin has a relevant misuse and dependence potential - more pronounced than gabapentin. In higher doses it can work euphoria-inducingly/relaxingly, which tempts to misuse, above all with a pre-existing addiction and in combination with other substances. Even with use as intended, a physical habituation arises (hence the tapering off). Take it only on medical instruction, do not increase, do not pass it on.
Pregabalin and opioids (e.g. tilidine, tramadol, morphine) both dampen the central nervous system - together they raise the risk of respiratory depression up to respiratory arrest. Authorities such as the BfArM (Germany) and the FDA have expressly warned. This combination may take place only under medical monitoring. Warning signs: strong sleepiness, slow/shallow breathing, confusion - then medical help immediately. This is also a common factor in pregabalin deaths.
Both work via the same mechanism. Pregabalin is absorbed more evenly, has to be taken only twice daily, can be built up faster, and is approved with anxiety disorder - but has a higher misuse potential. Gabapentin is often cheaper and somewhat less at risk of misuse, but has to be taken three times daily and built up more slowly. The choice is made by the doctor; with a history of addiction, caution is required.
No - pregabalin may not be stopped abruptly. A sudden stopping can trigger a discontinuation syndrome (sleep disorders, restlessness, anxiety, nausea, sweating) and provoke seizures in epilepsy patients. It should be tapered off slowly and medically accompanied over at least one week, often longer. With higher doses and longer use, the discontinuation symptoms can be more pronounced. Never stop on your own.
Better not. Pregabalin and alcohol both dampen the central nervous system - the combination enhances tiredness, dizziness, and light-headedness, raises the fall risk, and impairs the reaction. In combination with further dampening agents (opioids), the respiratory depression risk rises. In addition, the combination is partly sought to enhance the effect, which is particularly dangerous. During the therapy, avoid alcohol, when in doubt discuss with the doctor.
Yes - tiredness, sleepiness, and dizziness are among the most common side effects, above all in the dose-build-up phase. They often improve in the course. The slow dose build-up is helpful. Until the tolerability is clear, driving and operating machinery should be avoided. Alcohol and other dampening agents enhance these effects clearly.
A weight gain is common with longer use of pregabalin - through a raised appetite and water retention (oedema). The extent is individually different. Conscious nutrition and exercise help to counter-steer. With strong, burdensome weight gain or pronounced water retention, a dose adjustment or alternatives should be discussed with the doctor.
Yes, definitely. Pregabalin is excreted unchanged via the kidneys - with impaired kidney function the dose must be reduced clearly, otherwise it accumulates and the side effects (tiredness, dizziness, disturbances of consciousness) increase strongly. This is particularly relevant in older people. The adjustment is done medically according to the kidney function; with dialysis, special rules apply.
Federal Institute for Drugs and Medical Devices (BfArM, Germany) / FDA - safety notes on gabapentinoids (respiratory depression, misuse). bfarm.de
S3 guideline on the treatment of anxiety disorders (AWMF 051-028) (Germany). awmf.org
S2k guideline on diagnosis and non-interventional therapy of neuropathic pain (AWMF 030-114) (Germany). awmf.org
Drug Commission of the German Medical Association (AkdÄ) - gabapentinoids (Germany). akdae.de
Medical disclaimer: This article serves general information and does not replace medical advice, diagnosis, or therapy. Dosages and therapy decisions are always set individually by the doctor. Pregabalin has a relevant misuse potential, should be taken only on prescription, and never stopped abruptly (a seizure risk with epilepsy). The combination with opioids or sedatives can lead to life-threatening respiratory depression. With pronounced sleepiness with slowed breathing, call the emergency services immediately (112; or 999/112 in the UK). Last updated: May 2026.
.gif)
Pregabalin has a misuse potential. Never stop abruptly. The combination with opioids can lead to life-threatening respiratory depression. Dose adjustment with renal impairment. Last updated: May 2026.
